Login

Watch CNBC's full interview with Orange CEO Christel Heydemann discussing telecommunications and technology trends. 00:10:00

Share On Facebook Share On Twitter

Xavier Pichon is Chief Executive Officer at Orange Belgium. 

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Three AI Policy Updates to Limit Bias | Cooley AI
00:10:00
Fund Performance Review - December 2022 | Danilo Bredda - Member of the investment team at Alaska Investimentos,
00:00:00
Corline Biomedical - Naventus Healthcare Summit, May 10, 2022 - Henrik Nittmar, CEO at Corline Biomedical
00:10:00
Gain valuable insights into the strategic initiatives, innovative projects, and future prospects of Hecla Mining Company|Phillips S. Baker, Jr,President and CEO of Hecla Mining Company
00:10:00
Oslo City Shopping Center, Norway's bustling hub for transportation and commerce, prioritizes fire safety and security with over 11 million annual visitors and 1,000 employees.
00:10:00
Aims to open VC funding to tenacious and ambitious female founders|Jennifer Keiser Neundorfer,Co-Founder and Managing Partner,January Ventures
00:10:00
Uncovering Investment Opportunities Across Key Sectors
00:10:00
Values and Success: Building Legacy and Making a Difference at M&T
00:10:00
Rising Electricity and Gas Prices Raise Concerns for Residents and Businesses in Lithuania | Darius Maikštenas, CEO, Ignitis Grupe AB.
00:10:00
Exploring Untapped Gold Potential in the Lynn Lake Greenstone Belt: An Interview with Felix Lee, CEO of Willison Metals
00:10:00
Private Equity vs. ESOP: Key Differences in Ownership, Culture, and Benefits
00:10:00
Jeffries' Role in Cryptocurrency and Evolving Financial Trends

© 2026 Nehu